| Adenovirus | At least 69 type specific monoclonals and mixtures of monoclonals, including monoclonals against each of the adenovirus types 1-49 |
| Influenza | At least 61 monoclonals and mixtures of monoclonals against A and B types, including H3N2, H1N1 and others |
| Parainfluenza | At least 44 monoclonals and mixtures of monoclonals against types 1 through 4 |
| Respiratory Syncytial Virus (RSV) | At least 46 monoclonals and mixtures of monoclonals against types A and B |
| Coronavirus (SARS) | At least 36 monoclonals and mixtures of monoclonals to human coronavirus |
| Measles | At least 4 monoclonals and mixtures of monoclonals to nucleoprotein, matrix protein and hemagglutinin protein |
| Human Metapneumovirus | At least 39 monoclonals and mixtures of monoclonals to types A and B and subtypes |
| Rubella | At least 17 monoclonals and mixtures of monoclonals to capsid, E1 and E2 proteins |